ProPhase Labs Inc. Common Stock (DE)
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter (OTC) consumer healthcare products and dietary supplements in the United States. It offers a range of OTC dietary supplements, including Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support product; and Super ProstaFlow+ a supplement to support prostate and urinary health under the TK Supplements brand. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; and offers COVID-19 and other respiratory pathogen panel testing services. It serves consumer products companies, as well as large national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.
PRPH Overview
Sector |
Health Care |
Industry |
Major Pharmaceuticals |
Previous Close |
$7.0200 |
Previous Close Volume |
19050 |
Latest News
- ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures 11 Dec 2024 08:01:14
- ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024 13 Nov 2024 08:03:00
- ProPhase Labs Announces Closing of Public Offering of Common Stock 12 Nov 2024 16:33:03
- ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024 11 Nov 2024 10:02:37
- ProPhase Labs Announces Proposed Public Offering of Common Stock 07 Nov 2024 16:19:01
- ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry 04 Nov 2024 08:04:26
- ProPhase Labs to Present at the 2024 ThinkEquity Conference 22 Oct 2024 08:03:41
- ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025 17 Oct 2024 08:03:28
- ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event 19 Aug 2024 11:34:04
- ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024 14 Aug 2024 08:04:08
- ProPhase Labs Announces Collaboration with Forward Healthcare Consultants to Aid in the Commercialization of its Billion Dollar Potential BE-Smart Esophageal Cancer Test 13 Aug 2024 08:04:37
- PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14 07 Aug 2024 08:04:00
- ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress 11 Jul 2024 08:19:20
- ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. 09 May 2024 08:19:43
- PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9 02 May 2024 08:19:46
- ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 25 Apr 2024 08:04:43
- ProPhase Labs Unveils Project ZenQ-AI 16 Apr 2024 08:20:08
- ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024 10 Apr 2024 08:20:01
- ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives 15 Mar 2024 08:20:29
- PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024 08 Mar 2024 08:20:15
- ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART 20 Feb 2024 08:05:14
- ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir 14 Feb 2024 08:04:59
- ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics 30 Jan 2024 08:20:26
- Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts 23 Jan 2024 08:05:23